• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: July 18-22, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

July 18- July 22, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs7/18/11Stanford, CAN/ARepresentative Anna Eshoo (D-CA); Representative Nancy Pelosi (D-CA); Representative George Miller (D-CA); Representative Jackie Speier (D-CA)Biotechnology and Medical Device Industries in California
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs7/22/11Leesburg, VAN/AN/ASpeech at Conversations at Oatlands on Protecting and Promoting Public Health 
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs7/23/11Washington, DCN/AN/ARemarks at the National Medical Association’s 2011 Annual Convention and Scientific Assembly
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs7/21/11Silver Spring, MDDeb Autor, Lillian Gill, Carolyn Becker, Lisa Dwyer, Tania SimoncelliJanet Trunzo (AdvaMed); Minnie Baylor-Henry (Johnson & Johnson)Transparency and Globalization Initiative
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine7/21/11Rockville, MDMikeTaylor, William Flynn, Steve Vaughn, Dan McChesney, Caitlin BoonTodd Armstron, Jeff Simmons, Bill Weldon (Elanco)Portfolio Update
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Caroline Lewis, Acting Deputy Commissioner for Administration7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D.,  Director, Center for Biologics Evaluation and Research7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Meghan Scott, Acting Associate Commissioner for External Affairs7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs7/18/11-7/22/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research7/20/11Washington, DCMolly Muldoon, ShaAvhree Buckman, Celia Witten, Elizabeth MansfieldHenry Soloman (American College of Cardiology); Ellen Sigal (Friends of Cancer Research); Steven Weinberger (American College of Physicians); Julian Adams (Infinity Pharmaceuticals)President's Council of Advisors on Science and Technology Advancing Innovation in Drug Development and Evaluation Planning Meeting